HuGE Literature Finder
Records
1
-
2
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability. Journal of personalized medicine 2021 Mar 11 (3): . Zubiaur Pablo, Benedicto Maria Dolores, Villapalos-García Gonzalo, Navares-Gómez Marcos, Mejía-Abril Gina, Román Manuel, Martín-Vílchez Samuel, Ochoa Dolores, Abad-Santos Francis |
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions. Pharmacogenomics and personalized medicine 2020 3 13 59-70. Calderon-Ospina Carlos Alberto, Hernández-Sómerson Mario, García Ana María, Mejia Adriana, Tamayo-Agudelo Caroll, Laissue Paul, Fonseca Mendoza Dora Jane |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: